Both in Pharmaceuticals
PERRIGO vs Aurinia Pharmaceuticals
Over the past year PRGO returned −23.5% and AUPH returned +25.7%; their daily moves had a correlation of 0.06.
PRGO −23.5% AUPH +25.7%Growth of $1, one year, split-adjusted
| Metric | PRGO | AUPH |
|---|---|---|
| Price | $15.70 | $16.56 |
| Market cap | $2.18B | $2.22B |
| Today | −0.32% | +2.60% |
| 1 month | +8.7% | +5.3% |
| 6 months | +34.9% | +3.2% |
| Year to date | +12.8% | +3.8% |
| 1 year | −24.3% | +25.7% |
| Revenue growth (YoY) | −3.2% | +13.9% |
| Gross margin | 30.7% | 90.1% |
| Net margin | 7.3% | 37.9% |
| P/E (TTM) | — | 7.1× |
| Price / sales | 0.5× | 6.9× |
| Net cash | -$2.90B | $431.7M |
| Dividend yield | 7.39% | — |
| Volatility (60d) | 40.2% | 30.3% |
| Short % of float | 17.5% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).